BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 36946200)

  • 1. Investigations of
    Bashir B; Riaz N; Ejaz SA; Saleem M; Iqbal A; Ashraf M; Ejaz S; -Rehman AU; Aziz M; Bhattarai K
    J Biomol Struct Dyn; 2023; 41(24):15549-15568. PubMed ID: 36946200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular hybrids of substituted phenylcarbamoylpiperidine and 1,2,4-triazole methylacetamide as potent 15-LOX inhibitors: Design, synthesis, DFT calculations and molecular docking studies.
    Nawaz Z; Riaz N; Saleem M; Iqbal A; Abida Ejaz S; Bashir B; Muzaffar S; Ashraf M; Aziz-Ur-Rehman ; Sajjad Bilal M; Krishna Prabhala B; Sajid S
    Bioorg Chem; 2024 Feb; 143():106984. PubMed ID: 38056389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing p-tolyloxy-1,3,4-oxadiazole acetamides as lipoxygenase inhibitors assisted by in vitro and in silico studies.
    Bashir B; Riaz N; Abida Ejaz S; Saleem M; Ashraf M; Iqbal A; Muzaffar S; Ejaz S; Aziz-Ur-Rehman ; Mohammad Kashif Mahmood H; Bhattarai K
    Bioorg Chem; 2022 Dec; 129():106144. PubMed ID: 36116325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probing phenylcarbamoylazinane-1,2,4-triazole amides derivatives as lipoxygenase inhibitors along with cytotoxic, ADME and molecular docking studies.
    Muzaffar S; Shahid W; Riaz N; Saleem M; Ashraf M; Aziz-Ur-Rehman ; Bashir B; Kaleem A; Al-Rashida M; Baral B; Bhattarai K; Gross H
    Bioorg Chem; 2021 Feb; 107():104525. PubMed ID: 33317840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting new N-furfurylated 4-chlorophenyl-1,2,4-triazolepropionamide hybrids as potential 15-lipoxygenase inhibitors supported with
    Yasin M; Shahid W; Ashraf M; Saleem M; Muzaffar S; Ejaz SA; Mahmood HMK; Bhattarai K; Riaz N
    J Biomol Struct Dyn; 2023 Jul; 41(11):5166-5182. PubMed ID: 35699270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of phenylcarbamoylazinane-1,3,4-oxadiazole amides as lipoxygenase inhibitors with expression analysis and in silico studies.
    Bashir B; Shahid W; Ashraf M; Saleem M; Aziz-Ur-Rehman ; Muzaffar S; Imran M; Amjad H; Bhattarai K; Riaz N
    Bioorg Chem; 2021 Oct; 115():105243. PubMed ID: 34403937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring phenylcarbamoylazinane-1,2,4-triazole thioethers as lipoxygenase inhibitors supported with in vitro, in silico and cytotoxic studies.
    Shahid W; Ashraf M; Saleem M; Bashir B; Muzaffar S; Ali M; Kaleem A; Aziz-Ur-Rehman ; Amjad H; Bhattarai K; Riaz N
    Bioorg Chem; 2021 Oct; 115():105261. PubMed ID: 34416506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 4-Chlorophenyl-
    Yasin M; Shahid W; Ashraf M; Saleem M; Muzaffar S; Aziz-Ur-Rehman ; Ejaz SA; Saeed A; Majer T; Bhattarai K; Riaz N
    ACS Omega; 2022 Jun; 7(23):19721-19734. PubMed ID: 35721976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computational Investigation of 1, 3, 4 Oxadiazole Derivatives as Lead Inhibitors of VEGFR 2 in Comparison with EGFR: Density Functional Theory, Molecular Docking and Molecular Dynamics Simulation Studies.
    Bilal MS; Ejaz SA; Zargar S; Akhtar N; Wani TA; Riaz N; Aborode AT; Siddique F; Altwaijry N; Alkahtani HM; Umar HI
    Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36358960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel 1,2,4-oxadiazole-chalcone/oxime hybrids as potential antibacterial DNA gyrase inhibitors: Design, synthesis, ADMET prediction and molecular docking study.
    Ibrahim TS; Almalki AJ; Moustafa AH; Allam RM; Abuo-Rahma GEA; El Subbagh HI; Mohamed MFA
    Bioorg Chem; 2021 Jun; 111():104885. PubMed ID: 33838559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery and optimization of 2,3-diaryl-1,3-thiazolidin-4-one-based derivatives as potent and selective cytotoxic agents with anti-inflammatory activity.
    Shawky AM; Almalki FA; Abdalla AN; Youssif BGM; Abdel-Fattah MM; Hersi F; El-Sherief HAM; Ibrahim NA; Gouda AM
    Eur J Med Chem; 2023 Nov; 259():115712. PubMed ID: 37567059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, pharmacological screening and computational analysis of some 2-(1H-Indol-3-yl)-N'-[(un)substituted phenylmethylidene] acetohydrazides and 2-(1H-Indol-3-yl)-N'-[(un)substituted benzoyl/2-thienylcarbonyl]acetohydrazides.
    Rubab K; Abbasi MA; Rehman A; Siddiqui SZ; Shah SAA; Ashraf M; Ain Q; Ahmad I; Lodhi MA; Ghufran M; Shahid M; Fatima H
    Pak J Pharm Sci; 2017 Jul; 30(4):1263-1274. PubMed ID: 29039324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of Phenylcarbamoylazinane-1,2,4-Triazole Amides Derivatives as the Potential Inhibitors of Aldo-Keto Reductases (AKR1B1 & AKRB10): Potential Lead Molecules for Treatment of Colon Cancer.
    Saeed A; Ejaz SA; Sarfraz M; Tamam N; Siddique F; Riaz N; Qais FA; Chtita S; Iqbal J
    Molecules; 2022 Jun; 27(13):. PubMed ID: 35807227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, in Vitro Cholinesterase Inhibition, Molecular Docking, DFT, and ADME Studies of Novel 1,3,4-Oxadiazole-2-Thiol Derivatives.
    Tariq S; Mutahir S; Khan MA; Mutahir Z; Hussain S; Ashraf M; Bao X; Zhou B; Stark CBW; Khan IU
    Chem Biodivers; 2022 Aug; 19(8):e202200157. PubMed ID: 35767725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of NSAIDs as lipoxygenase inhibitors through highly sensitive chemiluminescence method, expression analysis in mononuclear cells and computational studies.
    Shahid W; Ejaz SA; Al-Rashida M; Saleem M; Ahmed M; Rahman J; Riaz N; Ashraf M
    Bioorg Chem; 2021 May; 110():104818. PubMed ID: 33784531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-activity tetracoordinated pallado-oxadiazole thiones as anti-inflammatory, anti-Alzheimer, and anti-microbial agents: Structure, stability and bioactivity comparison with pallado-hydrazides.
    Qurrat-Ul-Ain ; Abid A; Lateef M; Rafiq N; Eijaz S; Tauseef S
    Biomed Pharmacother; 2022 Feb; 146():112561. PubMed ID: 34965504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and synthesis of 4-aminophenol-1,3,4-oxadiazole derivative potentiates apoptosis by targeting MAP kinase in triple negative breast cancer cells.
    Dhanalakshmi B; Anil Kumar BM; Muddenahalli Srinivasa S; Vivek HK; Sennappan M; Rangappa S; Srinivasa Murthy V
    J Biomol Struct Dyn; 2023 Nov; ():1-16. PubMed ID: 37948299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-inflammatory efficacy and relevant SAR investigations of novel chiral pyrazolo isoquinoline derivatives: Design, synthesis, in-vitro, in-vivo, and computational studies targeting iNOS.
    Akhtar M; Niu J; Zhu Y; Luo Z; Tian T; Dong Y; Wang Y; Fareed MS; Lin L
    Eur J Med Chem; 2023 Aug; 256():115412. PubMed ID: 37146344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel 5-(Arylideneamino)-1
    Ali S; Ali M; Khan A; Ullah S; Waqas M; Al-Harrasi A; Latif A; Ahmad M; Saadiq M
    ACS Omega; 2022 Dec; 7(48):43468-43479. PubMed ID: 36506132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring ibuprofen derivatives as α-glucosidase and lipoxygenase inhibitors: Cytotoxicity and in silico studies.
    Daud S; Abid OU; Sardar A; Abdullah S; Shahid W; Ashraf M; Ejaz SA; Saeed A; Shah BA; Niaz B
    Arch Pharm (Weinheim); 2022 Aug; 355(8):e2200013. PubMed ID: 35532320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.